GDF11 and metabolic dysfunction-associated steatohepatitis: In summary, these data indicated that GDF11 may trigger the first stages of NASH development and fibrosis by HSCs activation and deposition of extracellular matrix (ECM) components in the absence of liver injury and inflammation.12